Literature DB >> 10717235

Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line.

J Adélaïde1, M Chaffanet, M J Mozziconacci, C Popovici, N Conte, F Fernandez, H Sobol, J Jacquemier, M Pébusque, D Ron, M Lafage-Pochitaloff, D Birnbaum.   

Abstract

Rearrangement and coamplification of the 8p12 and 11q13 chromosomal regions occurs in a significant proportion of breast cancers. It usually involves a complex hybrid structure in which the FGFR1 and CCND1 genes are amplified. We report here a different type of 8p12-11q13 rearrangement in the MDA-MB-175 mammary carcinoma cell line. This amplification contains the NRG1/HGL (from 8p12-21) and DOC4 (from 11q13) genes, encoding respectively a ligand for ERBB receptors and a stress-induced protein which is a mammalian ortholog of Drosophila Tenm/Odz. It has been shown previously (Wang et al, Oncogene 18: 5718-5721, 1999) that these two genes are rearranged and fused by a translocation event. This type of event was not found in 30 tumors tested that showed coamplification of the 8p12 and 11q13 regions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10717235     DOI: 10.3892/ijo.16.4.683

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  Mutation of l7Rn3 shows that Odz4 is required for mouse gastrulation.

Authors:  Amy C Lossie; Hisashi Nakamura; Sharon E Thomas; Monica J Justice
Journal:  Genetics       Date:  2004-10-16       Impact factor: 4.562

2.  Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines.

Authors:  Yih-Jyh Shann; Ching Cheng; Chun-Hui Chiao; Dow-Tien Chen; Pei-Hsin Li; Ming-Ta Hsu
Journal:  Genome Res       Date:  2008-02-06       Impact factor: 9.043

3.  FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma.

Authors:  Eleonora Brunello; Matteo Brunelli; Giuseppe Bogina; Anna Caliò; Erminia Manfrin; Alessia Nottegar; Marco Vergine; Annamaria Molino; Emilio Bria; Francesco Massari; Giampaolo Tortora; Sara Cingarlini; Serena Pedron; Marco Chilosi; Giuseppe Zamboni; Keith Miller; Guido Martignoni; Franco Bonetti
Journal:  J Exp Clin Cancer Res       Date:  2012-12-27

4.  Gamma-heregulin has no biological significance in primary breast cancer.

Authors:  E A Sánchez-Valdivieso; J J Cruz; R Salazar; M del Mar Abad; A Gómez-Alonso; A Gómez; R González-Sarmiento
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.